Ecolab Life Sciences announced the opening of a new Bioprocessing Applications Lab in Dongtan, Korea, its first bioprocessing facility in Asia. The new center further strengthens the company’s global Life Sciences footprint and supports customers operating in one of the world’s most advanced biopharmaceutical manufacturing markets.

Ecolab Life Sciences has launched an innovative new resin to help achieve cost savings and optimize operations throughout the antibody manufacturing process. Purolite™ AP+50 is an affinity chromatography resin with a 50-micron bead size offering the highest dynamic binding capacity of the AP resin platform while providing excellent durability for monoclonal antibody capture. It also leverages Ecolab’s patented Jetted resin bead manufacturing technology, an innovative approach that enables lot-to-lot consistency and shorter lead times.

This facility supports biopharma customers with applications and process development for biotherapeutic molecule purification, offering technical support from small-scale to full commercial production. Equipped with high-throughput process development tools and manufacturing scale chromatography columns, the lab helps biotech firms optimize processes and reduce costs. This new lab complements Ecolab’s existing European Applications and Research & Development Lab in Wales, UK.

Ecolab Inc., the world’s water, hygiene, and infection prevention company, today announced a further expansion of its Purolite business with the addition of a new biologics resin manufacturing facility in Landenberg, Pennsylvania.

Leading resin manufacturer Purolite extends and signs strategic partnership with Repligen for five new high-performance ligands to meet evolving bioprocessing market needs

Thursday, October 13 to celebrated the achievement of Purolite, an Ecolab company’s increased bioprocessing resin production to meet the growing demand for biopharmaceutical products globally.

Since 2015, Purolite and Alvotech have developed a strong partnership, fostered by a shared goal of improving the accessibility of essential biologic medicines. To achieve this, both companies focus on ingenuity and agility to enable more cost-effective solutions.

Purolite UK has kicked off the year by announcing Maggie’s Cancer Care Centre in Cardiff as its inaugural UK Charity of the Year for 2022.

Purolite Ltd., a leading manufacturer of resin-based separation, purification and extraction technologies, today announces that its Praesto agarose-based Protein A and Ion Exchange chromatography resins will be made available in South Korea and Singapore.

Purolite is happy to announce the promotion of Chrystal Stasicky from Administrative Assistant to Sales Support Specialist.

Purolite's Praesto range of agarose-based chromatography resins move into the commercial manufacturing of FDA-approved biotherapeutics.

Purolite Corporation is pleased to welcome Chrystal Stasicky, the company’s new administrator assistant.

James Roberts is the newest member of our Purolite team in the UK. James joins Purolite as Financial Planning and Analysis Manager.

Elunet Morgan, Baroness Morgan of Ely, Welsh Government Minister for International Relations and the Welsh Language visits Philadelphia

Andrew Talbot joins Purolite in Llantrisant, Wales, U.K. as the European Finance Analyst.